ArticleAlzheimer's research & therapy2023

Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline.

María Pascual-Lucas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.